Ozempic, a medication used to treat type 2 diabetes and promote weight loss, is gaining popularity in the pharmaceutical market due to its effectiveness in managing blood sugar levels. This trend reflects a broader focus on health and wellness among consumers.
The growing use of GLP-1 drugs, including Ozempic, has implications for various sectors within the US retail market. Companies such as Hershey, Lululemon Athletica, Mondelēz International, NIKE, PepsiCo, and Walmart are mentioned in this report, highlighting the potential impact on these businesses.
This exclusive report is only available to subscribers and provides valuable insights into the effects of widespread GLP-1 drug use on the retail industry. Subscribers can log in to access the document and gain a deeper understanding of this topic. If you are not a subscriber, you can learn more about subscriptions and access to relevant research.